Key facts
- It has raised $1.5M across 2 recorded rounds; the latest was Early Stage VC ($10.0M) in Jun 2026.
- Notable investors include Symbiotic Ventures.
- EyeCheq has filed 1 Form D with the SEC, most recently Jan 2025 ($1.6M sold to 8 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EyeCheq
Funding rounds
2 roundsAbout EyeCheq
Developer of an autonomous health and eye screening kiosk designed to help health plans and discover other visual and health problems. The company offers a self-guided kiosk system with automatic vision tests, retinal imaging and diagnostic interpretation, an online portal for results access and care coordination, enabling health care providers to screen patients for eye health conditions such as diabetic retinopathy, refer for follow-up care, and improve early detection in diverse care settings
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2021
- Website
- eyecheq.com/
- Ownership
- Privately Held (backing)
EyeCheq doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EyeCheq shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EyeCheq in its N-PORT filings yet. We sweep new filings monthly.